SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-217439
Filing Date
2021-07-16
Accepted
2021-07-16 16:22:59
Documents
8
Period of Report
2021-07-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d160939d8k.htm 8-K 28068
2 EX-4.1 d160939dex41.htm EX-4.1 82401
3 EX-4.2 d160939dex42.htm EX-4.2 82849
4 EX-5.1 d160939dex51.htm EX-5.1 7675
5 EX-10.1 d160939dex101.htm EX-10.1 172177
6 EX-99.1 d160939dex991.htm EX-99.1 13976
7 GRAPHIC g160939logolarge.jpg GRAPHIC 9398
8 GRAPHIC g160939logosmall.jpg GRAPHIC 2381
  Complete submission text file 0001193125-21-217439.txt   404864
Mailing Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462
Business Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462 617-467-4577
Allena Pharmaceuticals, Inc. (Filer) CIK: 0001624658 (see all company filings)

IRS No.: 452729920 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38268 | Film No.: 211095706
SIC: 2836 Biological Products, (No Diagnostic Substances)